• OPEN AN ACCOUNT
Indian Indices
Sensex
73,249.39 -460.30
( -0.62%)
Global Indices
Nasdaq
52,880.09 363.21
(0.69%)
Dow Jones
7,780.08 46.51
(0.60%)
Hang Seng
63,134.14 -1,487.10
(-2.30%)
Nikkei 225
10,723.99 -28.89
(-0.27%)
Forex
USD-INR
94.82 -0.08
(-0.09%)
EUR-INR
106.45 0.01
(0.01%)
GBP-INR
126.63 0.25
(0.20%)
JPY-INR
0.60 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

rajgor solvex ltd
Emami rallies after board approves share buyback at Rs 475 per share
Sep 17,2026
The company proposes to buy back up to 59,36,842 equity shares, representing 1.36% of its paid-up equity share capital as of 31 March 2026. The buyback price represents a premium of about 28.57% to the stock’s previous closing price of Rs 369.45.

The company will utilise at least 75% of the maximum buyback size, or Rs 211.50 crore, for the repurchase. Based on the maximum buyback price, the company would purchase a minimum of 44,52,632 shares. It will also utilise 40% of the maximum buyback size, or Rs 112.80 crore, during the first half of the buyback period.

The promoter shareholding will be 55.60% post-buyback from 54.84% in pre-buyback. The company said the final post-buyback shareholding pattern may vary depending on the number of equity shares acquired under the offer.

Emami is a FMCG company engaged in manufacturing & marketing of personal care & healthcare products. With over 550 diverse products, Emami’s portfolio includes trusted power brands like Navratna, BoroPlus, Fair & Handsome, Zandu Balm, Mentho Plus and Kesh King.

The company’s consolidated net profit declined 15.41% to Rs 137.35 crore in Q1 FY27, compared with Rs 164.26 crore in Q1 FY25. Revenue from operations jumped 14.95% YoY to Rs 1039.21 crore in Q1 FY26.